This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
medical-devices: Archive
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
by Zacks Equity Research
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
UHSPositive Net Change CORPositive Net Change AVAHPositive Net Change ATIPPositive Net Change
medical medical-devices
SNN Stock Rises on the Completion of First Case With CATALYSTEM System
by Zacks Equity Research
Smith & Nephew announces the completion of the first case using the CATALYSTEM Primary Hip System.
DGXNegative Net Change UHSPositive Net Change SNNNegative Net Change ABMPositive Net Change
medical medical-devices
GE HealthCare Shares Rise After AI-Powered Venue Sprint's Launch
by Zacks Equity Research
GEHC introduces Venue Sprint, a portable AI-enabled ultrasound device offering wireless probes, real-time insights and advanced clinical tools for improved care.
UHSPositive Net Change AVAHPositive Net Change ATIPPositive Net Change GEHCNegative Net Change
medical medical-devices
Implied Volatility Surging for Tactile Systems (TCMD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Tactile Systems (TCMD) stock based on the movements in the options market lately.
TCMDNegative Net Change
medical medical-devices
4 Stocks to Buy Amid Dental Supplies Industry Challenges
by Indrajit Bandyopadhyay
Here we discuss four stocks from the Dental Supplies industry that are likely to earn wealth for investors. These include BDX, MCK, COO and STAA.
BDXNegative Net Change MCKNegative Net Change COONegative Net Change STAANegative Net Change
medical medical-devices
Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
by Zacks Equity Research
Banking on strong sales of its contact lenses and ocular health products, ALC is registering solid growth within Vision Care.
BSXPositive Net Change ALCNegative Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
DGX Stock to Benefit From New Partnership With Sentara Health Plans
by Zacks Equity Research
Quest Diagnostics extends services in Virginia and Florida via a partnership with Sentara Health Plans.
BSXPositive Net Change DGXNegative Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
Here's Why You Should Retain McKesson Stock in Your Portfolio Now
by Zacks Equity Research
MCK's strategic collaborations and strength in Biologics raise optimism about the stock.
DGXNegative Net Change UHSPositive Net Change MCKNegative Net Change ABMPositive Net Change
medical medical-devices
GEHC Stock Rises as FDA Clears MIM Software's Centiloid Tool
by Zacks Equity Research
GE Healthcare's MIM Software announces the receipt of FDA clearance for its Centiloid scaling tool to perform PET-based amyloid imaging.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change GEHCNegative Net Change
medical medical-devices
VERO Stock Likely to Get Support From New Regulatory Nod in Australia
by Zacks Equity Research
The latest approval for Venus Concept in Australia reinforces its position as a global player in the aesthetic technology space.
AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change VERONegative Net Change
medical medical-devices
BD Stock Rises as Neopak XtraFlow Syringe Expands in Biologics
by Zacks Equity Research
BDX launches the Neopak XtraFlow Glass Prefillable Syringe, enhancing drug delivery for biologics and expanding capacity with new high-volume production lines.
BDXNegative Net Change UHSPositive Net Change AVAHPositive Net Change ATIPPositive Net Change
medical medical-devices
MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout
by Zacks Equity Research
Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.
BSXPositive Net Change BAXNegative Net Change DVAPositive Net Change MMSINegative Net Change
medical medical-devices
Abbott Stock Hurt by Macroeconomic Issues & FX Headwind
by Zacks Equity Research
Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the United States.
ABTNegative Net Change AXGNNegative Net Change KIDSNegative Net Change TMDXNegative Net Change
medical medical-devices
Here's Why You Should Retain Integer Holdings Stock in Your Portfolio Now
by Zacks Equity Research
ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.
BSXPositive Net Change BAXNegative Net Change DVAPositive Net Change ITGRNegative Net Change
medical medical-devices
TMO Stock to Gain From Expanded Bioanalytical Services in Sweden
by Zacks Equity Research
Thermo Fisher's PPD arm unveils a new facility in Sweden, expanding its bioanalytical capabilities.
BSXPositive Net Change TMONegative Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
Is Teleflex Stock a Smart Option for Your Portfolio Right Now?
by Zacks Equity Research
TFX instils optimism with its robust performance in the Interventional category and potential in Asia.
BSXPositive Net Change TFXNegative Net Change AXGNNegative Net Change TMDXNegative Net Change
medical medical-devices
MASI Stock Gains as US Court Raises Concern About Politan's Ethics
by Zacks Equity Research
Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor MASI's founder in the upcoming vote for new board members on Sept. 19.
BSXPositive Net Change BAXNegative Net Change DVAPositive Net Change MASIPositive Net Change
medical medical-devices
Stryker Stock Declines Despite Completion of care.ai Acquisition
by Zacks Equity Research
SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.
BSXPositive Net Change BAXNegative Net Change SYKNegative Net Change DVAPositive Net Change
medical medical-devices
Rockwell Medical Stock Surges 108.5% YTD: Should You Snap it Up Now?
by Urmimala Biswas
RMTI continues to outperform its peers, banking on its focus on optimizing business to drive sustainable profitability and meaningful cash flow generation.
EDAPNo Net Change IRIXNegative Net Change RMTIPositive Net Change
medical medical-devices
Merit Medical Stock Falls Despite Positive WRAPSODY Trial Results
by Zacks Equity Research
MMSI announces 6-month results from its WRAPSODY WAVE trial, showing superior efficacy in extending AV fistula patency for dialysis patients.
UHSPositive Net Change MMSINegative Net Change AVAHPositive Net Change ATIPPositive Net Change
medical medical-devices
CAH Stock May Gain Following the Distribution Agreement With Telix
by Zacks Equity Research
Cardinal Health and Telix announce an agreement selecting the former as a commercial radiopharmaceutical distributor to supply finished unit doses of Telix's Zircaix.
DGXNegative Net Change UHSPositive Net Change CAHPositive Net Change ABMPositive Net Change
medical medical-devices
CRL Stock to Gain From Strategic Neuroscience Partnership With CEBINA
by Zacks Equity Research
Charles River collaborates with CEBINA as part of the DanubeNeuro program to advance innovation in neurodegeneration.
BSXPositive Net Change CRLNegative Net Change AXGNNegative Net Change PAHCNegative Net Change
medical medical-devices
Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS
by Zacks Equity Research
MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.
BSXPositive Net Change BAXNegative Net Change DVAPositive Net Change MASIPositive Net Change
medical medical-devices
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
by Zacks Equity Research
ARAY's solid product demand and revenue growth raise optimism about the stock.
ARAYNegative Net Change DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change
medical medical-devices
NSPR Stock Declines Despite PMA Application Submission for CGuard
by Zacks Equity Research
InspireMD announces the submission of the PMA application to the FDA for marketing approval of the CGuard Prime EPS.
DGXNegative Net Change UHSPositive Net Change ABMPositive Net Change NSPRPositive Net Change
medical medical-devices